Antithrombotic effect of the type III collagen-related octapeptide (KOGEOGPK) in the mouse

Vascular Pharmacology

Volumn 44, Issue 1, 2006, Pages 42-49

  Maurice, Pascal ^a,b,c   Pires, Viviane ^d,e   Amant, Carole ^d,e   Kauskot, Alexandre ^a,b,c   Da Nascimento, Sophie ^d,e   Sonnet, Pascal ^d,e   Rochette, Jacques ^d,e   Legrand, Chantal ^a,b,c   Fauvel Lafeve, Françoise ^a,b,c   Bonnefoy, Arnaud ^a,b,c,f  

^a INSERM   (France)

^b IFR 105   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^e UPRES EA 2629   (France)

^f SAINT LOUIS HOSPITAL   (France)

Author keywords

Collagen; Mouse; Peptide; Platelet; Thrombosis

Indexed keywords

ADRENALIN; ANTICOAGULANT AGENT; COLLAGEN TYPE 3; LYSYLHYDROXYPROLINEGLYCYLGLUTAMYLHYDROXYPROLINEGLYCYLPROLYLLYSINE; OCTAPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; BLEEDING TIME; CECUM; COMPARATIVE STUDY; CONTROLLED STUDY; LUNG EMBOLISM; MALE; MOUSE; NONHUMAN; PHOTOCHEMISTRY; PRIORITY JOURNAL; THROMBOGENESIS; THROMBUS;

ANIMALS; ARTERIOLES; CECUM; COLLAGEN TYPE III; EPINEPHRINE; FIBRINOLYTIC AGENTS; LUNG; MICE; MICE, INBRED C57BL; PEPTIDES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PULMONARY EMBOLISM; ROSE BENGAL; THROMBOSIS; VENULES;

EID: 29144432855     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2005.09.006     Document Type: Article

References (29)

1. H.R. Baumgartner Platelet interaction with collagen fibrils in flowing blood: I. Reaction of human platelets with alpha chymotrypsin-digested subendothelium Thromb. Haemost. 37 1977 1 16
2. H.R. Baumgartner, T.B. Tschopp, and H.J. Weiss Platelet interaction with collagen fibrils in flowing blood: II. Impaired adhesion-aggregation in bleeding disorders. A comparison with subendothelium Thromb. Haemost. 37 1977 17 28
3. A. Baurand, P. Raboisson, M. Freund, C. Leon, J.P. Cazenave, J.J. Bourguignon, and C. Gachet Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist Eur. J. Pharmacol. 412 2001 213 221
4. J. Chen, T.G. Diacovo, D.G. Grenache, S.A. Santoro, and M.M. Zutter The alpha(2) integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis Am. J. Pathol. 161 2002 337 344
5. G. DiMinno, and M.J. Silver Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol J. Pharmacol. Exp. Ther. 225 1983 57 60
6. D.T. Durack Prevention of infective endocarditis N. Engl. J. Med. 332 1995 38 44
7. P.R. Erickson, and M.C. Herzberg The Streptococcus sanguis platelet aggregation-associated protein. Identification and characterization of the minimal platelet-interactive domain J. Biol. Chem. 268 1993 1646 1649
8. P.R. Erickson, M.C. Herzberg, and G. Tierney Cross-reactive immunodeterminants on Streptococcus sanguis and collagen. Predicting a structural motif of platelet-interactive domains J. Biol. Chem. 267 1992 10018 10023
9. R.W. Farndale, J.J. Sixma, M.J. Barnes, and P.G. de Groot The role of collagen in thrombosis and hemostasis J. Thromb. Haemost. 2 2004 561 573
10. F. Fauvel, Y.J. Legrand, K. Kuhn, H. Bentz, P.P. Fietzek, and J.P. Caen Platelet adhesion to type III collagen: involvement of a sequence of nine aminoacids from alpha 1 (III) CB peptide Thromb. Res. 16 1979 269 273
11. C.J. Foster, D.M. Prosser, J.M. Agans, Y. Zhai, M.D. Smith, J.E. Lachowicz, F.L. Zhang, E. Gustafson, F.J. Monsma Jr., M.T. Wiekowski, S.J. Abbondanzo, D.N. Cook, M.L. Bayne, S.A. Lira, and M.S. Chintala Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs J. Clin. Invest. 107 2001 1591 1598
12. L. He, L.K. Pappan, D.G. Grenache, Z. Li, D.M. Tollefsen, S.A. Santoro, and M.M. Zutter The contributions of the alpha 2 beta 1 integrin to vascular thrombosis in vivo Blood 102 2003 3652 3657
13. M.C. Herzberg, G.D. MacFarlane, K. Gong, N.N. Armstrong, A.R. Witt, P.R. Erickson, and M.W. Meyer The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis Infect. Immun. 60 1992 4809 4818
14. O. Holtkotter, B. Nieswandt, N. Smyth, W. Muller, M. Hafner, V. Schulte, T. Krieg, and T. Eckes Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen J. Biol. Chem. 277 2002 10789 10794
15. A. Karniguian, Y.J. Legrand, P. Lefrancier, and J.P. Caen Effect of a collagen derived octapeptide on different steps of the platelet/collagen interaction Thromb. Res. 32 1983 593 604
16. K. Kato, T. Kanaji, S. Russell, T.J. Kunicki, K. Furihata, S. Kanaji, P. Marchese, A. Reininger, Z.M. Ruggeri, and J. Ware The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion Blood 102 2003 1701 1707
17. S. Massberg, M. Gawaz, S. Gruner, V. Schulte, I. Konrad, D. Zohlnhofer, U. Heinzmann, and B. Nieswandt A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo J. Exp. Med. 197 2003 41 49
18. E. Melis, A. Bonnefoy, K. Daenens, H. Yamamoto, J. Vermylen, and M.F. Hoylaerts AlphaIIbbeta3 antagonism vs. antiadhesive treatment to prevent platelet interactions with vascular subendothelium J. Thromb. Haemost. 2 2004 993 1002
19. M.W. Meyer, K. Gong, and M.C. Herzberg Streptococcus sanguis-induced platelet clotting in rabbits and hemodynamic and cardiopulmonary consequences Infect. Immun. 66 1998 5906 5914
20. E. Monnet, and F. Fauvel-Lafeve A new platelet receptor specific to type III collagen. Type III collagen-binding protein J. Biol. Chem. 275 2000 10912 10917
21. B. Nieswandt, V. Schulte, W. Bergmeier, R. Mokhtari-Nejad, K. Rackebrandt, J.P. Cazenave, P. Ohlmann, C. Gachet, and H. Zirngibl Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice J. Exp. Med. 193 2001 459 469
22. J.G. Pickering, C.M. Ford, and L.H. Chow Evidence for rapid accumulation and persistently disordered architecture of fibrillar collagen in human coronary restenosis lesions Am. J. Cardiol. 78 1996 633 637
23. J. Rauterberg, E. Jaeger, and M. Althaus Collagens in atherosclerotic vessel wall lesions Curr. Top. Pathol. 87 1993 163 192
24. B. Savage, F. Almus-Jacobs, and Z.M. Ruggeri Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow Cell 94 1998 657 666
25. P. Sonnet, S. Da Nascimento, D. Marty, N. Franceschini, J. Guillon, J.D. Brion, and J. Rochette First synthesis of segetalins B and G: two cyclopentapeptides with estrogen-like activity Tetrahedron Lett. 44 2003 3293 3296
26. E.J. Topol, T.V. Byzova, and E.F. Plow Platelet GPIIb-IIIa blockers Lancet 353 1999 227 231
27. K. Vanhoorelbeke, H. Ulrichts, A. Schoolmeester, and H. Deckmyn Inhibition of platelet adhesion to collagen as a new target for antithrombotic drugs Curr. Drug. Targets. Cardiovasc. Haematol. Disord. 3 2003 125 140
28. H.J. Weiss Platelet physiology and abnormalities of platelet function (first of two parts) N. Engl. J. Med. 293 1975 531 541
29. H.J. Weiss Platelet physiology and abnormalities of platelet function (second of two parts) N. Engl. J. Med. 293 1975 580 588